Growth Analyser Growth Analyser

Compare funds

Pick up to 10 funds. Compare funds from the same category for a fair reading.

Tata India Pharma & Healthcare Fund · Direct ✕Axis ESG Integration Strategy Fund · Direct ✕

Growth of ₹10,000

Basics

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
CategorySectoral / ThematicSectoral / Thematic
PlanDirectDirect
Fund houseTataAxis
AUM₹1,534 Cr₹1,063 Cr
NAV₹38.9215₹22.8900
NAV date20 Nov 202620 Nov 2026
History—6.8 years
Expense ratio1.1%1.8%
StarsNot rated★★★★★
Growth Score—27.90

AUM: AMFI's average assets under management for July - September 2026, in ₹ crore, for the whole fund (Direct and Regular, Growth and IDCW added up). The same source and period for every fund, so the figures compare.

Returns

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
1 month—+6.66%
3 months—−0.17%
6 months—+4.33%
YTD—−3.13%
1 year—−3.09%
3 years (CAGR)—+8.47%
5 years (CAGR)—+5.41%
10 years (CAGR)——
Since launch—+12.87%

Risk

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
Volatility—14.1%
Downside volatility—10.3%
Sharpe—0.14
Sortino—0.19
Calmar—0.48
Return / risk—0.60
Deepest fall—−24.30%
Days to recover—517
Below its high—−7.66%

Against benchmark

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
Alpha——
Beta——
R²——
Up capture——
Down capture——
Tracking error——
Information ratio——
Treynor——

Consistency

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
Best 1-year—+70.80%
Middle 1-year—+9.41%
Worst 1-year—−16.36%
1-year periods with a loss—28.8%
Middle 3-year—+13.11%
Positive months—63.9%
Best day—+3.71%
Worst day—−3.53%
Worst 5% day—−1.22%
Positive days—52.6%
NAVs a year—251

SIP of ₹10,000 a month

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
5-year XIRR—+7.32%
5-year value—₹7,24,420
3-year XIRR—+3.16%
1-year XIRR—+2.79%

Holdings overlap i

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
Tata India Pharma & Healthcare Fund
Direct · filing Oct 2026
—7%
Axis ESG Integration Strategy Fund
Direct · filing Oct 2026
7%—

Share of money in the same stocks, by weight. Above 50% means much of one fund repeats the other.

Tata India Pharma & Healthcare Fund and Axis ESG Integration Strategy Fund

Overlap
7.4%
smaller weight of each shared stock, added up
Stocks in common
4
of 39 and 40
Weight in common
15% · 7%
of each fund's money
Filings compared
Oct 2026 · Oct 2026
same month
Common stockTata India Pharma & Healthcare FundAxis ESG Integration Strategy FundCounts toward overlap
Sun Pharmaceutical Industries Limited7.89%2.77%2.77%
Biocon Limited2.23%2.29%2.23%
Anthem Biosciences Limited2.99%1.67%1.67%
Alkem Laboratories Limited1.40%0.73%0.73%
4 stocks14.5%7.5%7.4%

Only in Tata India Pharma & Healthcare Fund (35)

Abbott India Limited5.66%
Divi's Laboratories Limited5.41%
Healthcare Global Enterprises Limited5.25%
Dr. Reddy's Laboratories Limited5.14%
Torrent Pharmaceuticals Limited4.73%
Apollo Hospitals Enterprise Limited4.55%
Max Healthcare Institute Limited4.28%
Rainbow Childrens Medicare Limited4.02%
Sai Life Sciences Limited3.22%
Syngene International Limited3.17%
Procter & Gamble Health Limited3.15%
Lupin Limited3.13%
Cipla Limited3.08%
Natco Pharma Limited2.86%
FDC Limited2.69%
Bayer Cropscience Limited2.68%
Acutaas Chemicals Limited2.40%
Pfizer Limited2.40%
Aster DM Quality Care Limited2.33%
Navin Fluorine International Limited2.15%
Sanofi Consumer Healthcare India Limited1.99%
Ajanta Pharma Limited1.59%
Dr Agarwal's Health Care Ltd1.31%
Gillette India Limited1.25%
Nestle India Limited1.09%

and 10 smaller holdings (5.7% of the fund).

Only in Axis ESG Integration Strategy Fund (36)

Reliance Industries Limited8.36%
ICICI Bank Limited6.78%
Clean Max Enviro Energy Solutions Limited6.70%
Bajaj Finance Limited5.72%
Titan Company Limited5.07%
Axis Bank Limited3.79%
Shriram Finance Limited3.71%
PVR Inox Limited3.48%
Pidilite Industries Limited3.04%
Piramal Finance Limited2.80%
Coforge Limited2.80%
Bharat Heavy Electricals Limited2.24%
Varun Beverages Limited2.14%
Arvind Limited2.02%
Chalet Hotels Limited1.76%
Metropolis Healthcare Limited1.74%
TBO Tek Limited1.59%
CG Power and Industrial Solutions Limited1.59%
TD Power Systems Limited1.49%
Star Health And Allied Insurance Co Limited1.41%
Cummins India Limited1.39%
IPCA Laboratories Limited1.35%
Eicher Motors Limited1.22%
SBI Life Insurance Company Limited1.04%
National Stock Exchange Of India Limited1.01%

and 11 smaller holdings (5.0% of the fund).

Method: from each fund's latest monthly portfolio filing, shares only (Indian and foreign equity; bonds, cash and derivatives are left out). Overlap adds up, for every stock both hold, the smaller of the two weights.

Sectors and company size

Tata India Pharma & Healthcare FundAxis ESG Integration Strategy Fund
Large companies26.8%49.8%
Mid companies30.4%13.1%
Small companies40.2%21.2%
Top 10 holdings50.1%49.5%
Largest sectorPharmaceuticals & Biotechnology 64%Finance 13%

Search Growth